TG Therapeutics Inc ECTRIMS Investor & Analyst Event Transcript
(Operator Instructions) As a reminder, this conference is being recorded.
It's now my pleasure to turn the call over to Jenna Bosco. Please go ahead.
Good morning, and thank you all for joining us. I'm Jenna Bosco, the Head of Corporate Communications for TG Therapeutics. And we're excited to review with you all today the data presented at the ECTRIMS 2021 Congress.
Before we begin, I wanted to remind everyone that we anticipate making some forward-looking statements based on our current expectations. These statements involve risks and uncertainties that may cause our actual results to differ materially from those indicated. For a description of these risks, we encourage you to review the disclosures on this slide and also in our latest reports filed with the SEC, which are available on our corporate website at www.tgtherapeutics.com.
With that, let's kick things off with a
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |